Diagnostic and therapeutic potential of microRNAs in neuropsychiatric disorders: Past, present, and future
- 1 February 2017
- journal article
- review article
- Published by Elsevier in Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Vol. 73, 87-103
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Mental Health (R33MH087896, R01MH091115, R01MH095088)
- Pitt–Hopkins Research Foundation
This publication has 163 references indexed in Scilit:
- Alterations of Serum Levels of BDNF-Related miRNAs in Patients with DepressionPLOS ONE, 2013
- Gene-microRNA interactions associated with antipsychotic mechanisms and the metabolic side effects of olanzapinePsychopharmacology, 2013
- Exome Sequencing Followed by Large-Scale Genotyping Suggests a Limited Role for Moderately Rare Risk Factors of Strong Effect in SchizophreniaThe American Journal of Human Genetics, 2012
- Genetic association of the Phosphoinositide‐3 kinase in schizophrenia and bipolar disorder and interaction with a BDNF gene polymorphismBrain and Behavior, 2011
- Altered MicroRNA Expression Profiles in Postmortem Brain Samples from Individuals with Schizophrenia and Bipolar DisorderBiological Psychiatry, 2011
- The Basics of Brain DevelopmentNeuropsychology Review, 2010
- RNA‐Seq: A Method for Comprehensive Transcriptome AnalysisCurrent Protocols in Molecular Biology, 2010
- A MicroRNA gene is hosted in an intron of a schizophrenia-susceptibility geneSchizophrenia Research, 2009
- Prediction of Mammalian MicroRNA TargetsCell, 2003
- Variation of the CGG repeat at the fragile X site results in genetic instability: Resolution of the Sherman paradoxCell, 1991